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obese rats through coordinated control of AMPK
signaling in the liver and adipose tissue
Elly Ok†, Gyeong-Min Do†, Yeni Lim, Ji-Eun Park, Yeo-Jin Park and Oran Kwon*Abstract
Background: The effect of pomegranate vinegar (PV) on adiposity was investigated in high-fat diet (HF)-induced
obese rats.
Methods: The rats were divided into 5 groups and treated with HF with PV or acetic acid (0, 6.5 or 13% w/w) for
16 weeks. Statistical analyses were performed by the Statistical Analysis Systems package, version 9.2.
Results: Compared to control, PV supplementation increased phosphorylation of AMP-activated protein kinase
(AMPK), leading to changes in mRNA expressions: increases for hormone sensitive lipase and mitochondrial
uncoupling protein 2 and decreases for sterol regulatory element binding protein-1c (SREBP-1c) and peroxisome
proliferator-activated receptorγ (PPARγ) in adipose tissue; increases for PPARα and carnitinepalmitoyltransferase-1a
(CPT-1a) and decrease for SREBP-1c in the liver. Concomitantly, PV reduced increases of body weight (p = 0.048), fat
mass (p = 0.033), hepatic triglycerides (p = 0.005), and plasma triglycerides (p = 0.001).
Conclusions: These results suggest that PV attenuates adiposity through the coordinated control of AMPK, which
leads to promotion of lipolysis in adipose tissue and stimulation of fatty acid oxidation in the liver.
Keywords: High-fat diet-induced obesity, Pomegranate vinegar, AMP-activated protein kinase, Hormone sensitive
lipase, Fatty acid oxidationBackground
Obesity is a chronic metabolic disorder that is charac-
terized by excessive body fat and dysregulation of lipid
metabolism. Hyperlipidemia in obesity is strongly asso-
ciated with chronic diseases such as type 2 diabetes,
cardiovascular disease, certain forms of cancer, and re-
spiratory complications [1]. Currently two categories of
medications are available to treat obesity: appetite sup-
pressants and inhibitors of specific nutrient absorption.
However, they often have undesirable side-effects.
Therefore much attention has been focused on na-
tural products, which may increase fat oxidation, de-
crease adipogenesis, and regulate lipid metabolism.
AMP-activated protein kinase (AMPK) is regarded as
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stated.plays a critical role in the energy balance of the body
through a concomitant inhibition of fatty acid synthe-
sis and an activation of fatty acid oxidation [2]. Meta-
bolic changes induced by AMPK involve both acute
effects on the phosphorylation of key enzymes and
chronic effects on the expression of genes involved in
metabolic regulation [3]. Thus, AMPK has been recog-
nized as a promising target for the management of obesity
and hyperlipidemia.
Dietary acetic acid is metabolized to acetyl-CoA with
the production of AMP [4], which, in vitro, results in the
elevation of the AMP/ATP ratio and subsequent phos-
phorylation of AMPK [5]. Based on these findings, pre-
vious studies found that dietary acetic acid suppressed
body fat accumulation in animals by regulating genes for
energy consumption and fatty acid oxidation enzymes in
liver [6]. However, the effects of dietary acetic acid on
AMPK activation in adipose tissue remains relatively un-
explored, although AMPK is ubiquitously expressed andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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pathological processes in the liver and adipose tissue [7].
Furthermore, little information is available on the coor-
dinated control of lipid metabolism through the phos-
phorylation of each AMPK protein and its downstream
effectors in the liver and adipose tissue.
Finally, as many different kinds of vinegars are being
introduced into the market, it is necessary to compare
the relative bioactivities of newer vinegars. Pomegranate
(Punicagranatum L.), a fruit native to the Middle East,
and its juice and extracts are being widely promoted to
consumers as a nutraceutical source. Therefore, this
study was performed to compare the effects of new vi-
negar containing pomegranate extract (PV) with those
of acetic acid on adiposity in high-fat diet-induced obese
(DIO) rats. To provide mechanistic explanation, we also
investigated the role of AMPK protein and its down-
stream effectors with a focus on the coordinated control
of lipid metabolism between the liver and adipose tissue.
Results and discussion
In this study, the effects of PV on adiposity were com-
pared with those of acetic acids in DIO rats, which have
characteristics of excess body fat, dyslipidemia, and fatty
liver.
Comparison of PV and acetic acid for attenuating
adiposity in DIO rats
Changes in body weight, calorie intake, fat weight, and
lipid profile in plasma and liver after a 16-week supple-
mentation with PV or acetic acid are shown in Table 1.
Although daily calorie intake was not different among
the groups, both AH and VL supplementation signi-
ficantly suppressed body weight increases induced by a
high-fat diet (p = 0.048). Also AH or VL groups were
also shown to decrease WAT. However, the dose-de-
pendency was not clear in PV, resulting that changes in
body weight and WAT were notably decreased in the VLTable 1 Effects of acetic acid or pomegranate vinegar supple
weight, and lipid profile in plasma and liver in Sprague Dawl
HF AL
Body weight gain (g/16 weeks) 268.6 ± 10.6a 247.2 ± 10.3
Calorie intake (kcal/day) 107.8 ± 2.2 104.1 ± 3.
WAT mass (g/100 g BW)
Epididymal WAT 3.4 ± 0.1a 3.4 ± 0.0a
Perirenal WAT 4.8 ± 0.2a 4.5 ± 0.1a
Plasma TG (mg/dL) 186.6 ± 8.9a 155.5 ± 10.
Plasma leptin (ng/mL) 10.2 ± 0.5 10.20 ± 0.
Hepatic TG (mg/g liver) 36.7 ± 4.5a 30.8 ± 3.0a
Mean ± SEM (n = 10 per group). abMeans not sharing common letters are significant
body weight; WAT, white adipose tissue; TG, triglycerides; HF, high fat diet; AL, high
high-dose acetic acid; VL, HF with low-dose PV; VH, HF with high-dose PV.group. Plasma triglyceride (TG) level was significantly
lowered by acetic acid or PV supplementation compared
with the HF control (p = 0.001), whereas plasma leptin
level was tended to be decreased in the VL group only.
Hepatic TG level was significantly lowered in the VL
group versus the HF control (p = 0.005). These findings
are consistent with data on body weight gain and
adiposity.
It is worth to note that the effects of PV on fat
utilization in the liver and decrease in body weight and
plasma triglycerides were more potent at the low-dose
than the high-dose, but the effects of low-dose PV
showed slightly more or equal potency than high-dose
acetic acid. It might be attributed to the chemical com-
position of PV. However, a limitation of this study is that
it was not designed to aim at tracing the causative com-
ponents in PV due to the highly diverse phytochemicals
found in PV. Further complicating matters, phytochemi-
cals are transformed in the body into various metabolites
after ingestion [8]. Future studies are needed to identify
the principal bioactive components in PV, such as tes-
ting the activity of each fraction in a suitable cell culture
model or high-throughput assay system [9]. In the mean-
time, ellagic acid that was recognized as having a potential
role in contributing to altered gene expression by PV
treatment in human hepatocyte in a less-specific approach
[10] can be used as a marker compound for the purpose
of standardizing PV.
Effects of PV on the activation of AMPK and its
downstream effectors in adipose tissue
Lipolysis in WAT is completed in a step-wise fashion
initiated by adipose TG lipase and then hormone sen-
sitive lipase (HSL) and monoacylglycerol lipase [11].
Existing literature indicates that high-fat diet feeding
increased adipose TG lipase content in mouse, whereas
activated HSL content was severely reduced [12], indi-
cating that the hydrolysis of diacylglycerol by HSL is thementation on the body weight gain, calorie intake, fat
ey rats fed a high fat diet for 16 weeks
AH VL VH
ab 230.5 ± 5.1b 235.3 ± 12.8b 259.6 ± 12.3ab
1 107.4 ± 1.5 104.1 ± 3.1 106.2 ± 1.8
b 3.3 ± 0.0ab 3.0 ± 0.1b 3.2 ± 0.1ab
b 4.3 ± 0.1b 4.3 ± 0.1b 4.4 ± 0.1ab
8b 152.7 ± 8.1b 154.6 ± 10.4b 164.6 ± 10.1b
9 9.9 ± 0.4 8.5 ± 0.4 9.84 ± 0.6
b 30.0 ± 4.7ab 23.8 ± 1.9b 28.4 ± 3.1ab
ly different between groups at p < 0.05 by Duncan’s multiple range tests. BW,
fat with HF, high fat diet; AL, HF with low-dose acetic acid; AH, HF with
Figure 1 (See legend on next page.)
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Figure 1 Effects of pomegranate vinegar or acetic acid supplementation on the p-AMPK protein (A), PPARγ (B), SREBP-1c (C), HSL (D),
UCP2 (E), CPT-1a (F) mRNA levels in adipose tissue of SD rats fed a HF diet for 16 weeks (n = 10 per group). Representative western blots
of adipose tissue lysate with antibodies against AMPK, p-AMPK and β-actin as loading control. Total protein (50 ug) from the adipose tissue was
electrophoresed on to SDS-phage gel and transferred to PVDF membranes. The effects of dietary PV or acetic acid supplementation on key
lipolysis enzyme mRNA levels were examined by real-time PCR. The results represent each mRNA/ β-actin expression ratio. Data are shown as the
mean ± SEM. abcMeans not sharing common letters are significantly different between groups at p < 0.05.
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found that high-fat diet inhibited AMPK activation as
well as PPARγ coactivator-1α expression, citrate syn-
thase activity, and palmitate oxidation in WAT [12].
However, PV supplementation prevented high-fat diet
induced changes in WAT as witnessed by up-regulation
of HSL expression, down-regulation of SREBP-1c and
PPARγ expression, and induction of AMPK activation in
this study. Adipogenesis involves a highly regulated and
coordinated cascade of transcription factors, such as
members of the PPARs, the C/EBPs, and SREBP family,
which together lead to the establishment of the differen-
tiated state [14]. SREBP-1c, the most abundant form of
SREBPs in adipose tissue and liver, controls the genes in-
volved in lipogenesis. PPARγ also remarkably distributes
in WAT and plays a crucial role in maintaining adipose
expansion and adiposity [15]. AMPK signaling pathways
have shown an inverse correlation with SREBP-1c as
well as PPARγ in WAT [16]. Figure 1A shows the acti-
vaion of AMPK in WAT, indicating the phospho-AMPK
levels in WAT were increased in the acetic acid and PV
groups compared with the HF control. Expression of
PPARγ mRNA was significantly decreased in VL group
versus HF control (Figure 1B). In parallel with this, the
expression of SREBP-1c mRNA was significantly de-
creased in the AL, VL, and VH groups compared to the
HF control (Figure 1C). In contrast, the expression of
HSL mRNA was significantly higher in the PV groups
versus the HF control (Figure 1D). In particular, the VL
group showed much greater increase in comparison to
the HF control. The biological role of uncoupling pro-
tein2 (UCP2) is less clear, although some evidence sug-
gests a role for this protein in energy balance and
thermogenesis [17]. The results of the present study in-
dicate that UCP2 mRNA was also significantly increased
in the VL group only in comparison to the HF control
(Figure 1E) in adipose tissue. However, CPT-1a, the rate-
limiting enzyme of mitochondrial fatty acid oxidation,
mRNA level was not changed with acetic acid or PV
supplementation (Figure 1 F). Collectively, it appeared
that PV promoted lipolysis as well as created milieu for
preventing re-esterification of lipolytic products in WAT.
Therefore, the net result was to favor lipid removal from
WAT. The classical mechanism to explain these charac-
teristics is highlighted by fact that dysregulation of lipoly-
sis may lead to metabolic abnormalities [18,19].Effects of PV on the activation of AMPK and its
downstream effectors in the liver
Abnormalities of peripheral lipid storage in obesity may
result in overflow of lipid to the liver, leading to hepatic
fat accumulation [20]. This study revealed that PV pro-
moted fatty acid oxidation and inhibited lipogenesis in
the liver as evidenced by the phosphorylation of AMPK
as well as up-regulation of PPARα and CPT-1a ex-
pression and down-regulation of SREBP-1c expression.
AMPK has been identified as a key regulator of lipid
homeostasis in the liver [21], yielding a net effect of
increasing fatty acid oxidation and diminishing glyce-
rolipid synthesis. Figure 2A shows the increase in the
AMPK phosphorylation after acetic acid or PV supple-
mentation as compared to the HF control. In addition,
the expression of both lipogenesis- and fatty acid oxida-
tion-related genes was determined in the liver. The ex-
pressions of PPARα and CPT-1a mRNA were stimulated
in the AH, VL, and VH group compared to the HF con-
trol (Figure 2B and C, respectively), while the expression
of SREBP-1c mRNA, a transcription factor controlling
lipogenesis, significantly declined only in the AH group,
but tended to decrease in the AL, VL, and VH groups
compared to the HF control (Figure 2D). The expres-
sions of acyl-CoA oxidase (ACO) and UCP2 mRNA
were not changed (Figure 2E and F, respectively). The ef-
fect of PV is not significantly different compared with
that of acetic acid. These results are in agreement with
the study by Kondo et al. [6] who found up-regulation
of PPARα, ACO, CPT-1 and UCP2 genes after the
addition of acetic acid to HepG2 cells. However, the up-
regulation of PPARα and CPT-1a mRNA expressions
and the phosphorylation of AMPK were more pro-
nounced with PV than with acetic acid.
Coordinated control of energy metabolism by PV in
adipose tissue and liver
Vinegar intake reduced body weight, body fat mass, and
serum triglyceride levels in obese Japanese subjects and
attenuated lipid profile in diabetic rats [22,23]. In ad-
dition, dietary acetic acid reduces serum cholesterol and
triacylglycerols in rats fed a cholesterol-rich diet [24]. In
this study, PV showed higher potency than acetic acid in
promoting lipolysis via increase of HSL mRNA in adi-
pose tissue as well as fatty acid oxidation via increase of
CPT-1a mRNA in liver. Taken together, our data support
Figure 2 (See legend on next page.)
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Figure 2 Effects of pomegranate vinegar or acetic acid supplementation on the p-AMPK protein (A), PPARα (B), CPT-1a (C), SREBP-1c
(D), ACO (E), UCP2 (F) mRNA levels in the liver of SD rats fed a HF diet for 16 weeks (n = 10 per group). Representative western blots of
adipose tissue lysate with antibodies against AMPK, p-AMPK and β-actin as loading control. Total protein (40 ug) from the liver was electrophoresed
on to SDS-phage gel and transferred to PVDF membranes.The effects of dietary PV or acetic acid supplementation on hepatic key lipolysis enzyme
mRNA levels were examined by real-time PCR. Data are shown as the mean ± SEM. abcMeans not sharing common letters are significantly
different between groups at p < 0.05.
Table 2 Composition of pomegranate vinegar
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trol of energy metabolism through AMPK activation be-
tween liver and adipose tissue better than acetic acid.
Especially, these findings, at molecular level, firmly
proved that the low-dose PV exerted higher potency
than the high-dose PV in adipose tissue. Adipose tissue
stores excess energy under positive energy balance con-
ditions, whereas it provides energy for other organs by
releasing fatty acids under negative energy balance con-
ditions. Excess fatty acids release from the adipose tissue
may cause fatty acid overflux into the liver with the de-
velopment of liver steatosis. The coordinated control of
lipid metabolism between these two organs might be
important to maximize the overall effectiveness of lipid
disposal. It created an environment where the net meta-
bolic effect is to favor lipid removal, which was asso-
ciated with the interaction between p-AMPK-induced
up-regulation of HSL mRNA and down-regulation of
PPARγ and SREBP-1c mRNA in adipose tissue and
AMPK-induced up-regulation of PPARα and CPT-1a
mRNA and down-regulation of SREBP-1c mRNA in
liver.
Conclusions
Consequently, PV prevented hepatic lipid deposition by
overflow of lipid to the liver resulting from abnormalities
of peripheral lipid storage in HF status. It suggests that
AMPK activation of PV might act as an energy sensor
between liver and adipose tissue to improve metabolic
health. Further study is warranted to investigate whether
PV intake may help to protect dyslipidemia and to main-
tain a healthy body weight in overweight subjects.
Methods
Chemicals
Acetic acid and ellagic acid were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Antibodies (AMPK and
phospho-AMPK) were purchased from Cell Signaling
Technology (Denver, MA, USA). All solvents were pur-
chased from Merck (Darmstadt, Germany).
Materials
The PV was obtained from Daesang Corp. (Seoul, Korea).
Briefly, pomegranate extract was added after the alcohol
fermentation and then acetic acid fermentation was con-
tinued. The PV was standardized with acetic acid andellagic acid by using high-performance liquid chromato-
graphy (HPLC, Agilent Technologies 1200, Santa Clara,
CA, USA, Table 2). Acetic acid was analyzed using Ami-
nex HPX-87H cation-exchange column (300 × 7.8 mm;
Bio-Rad, Hercules, CA, USA) and a UV detector (210 nm);
ellagic acid was analyzed using C18 Halo column
(100 × 2.1 mm; HiChrom, Berkshire, UK) and a UV
detector (360 nm) as described in our previous study [10].
Animal and diets
Ten-week-old male Sprague–Dawley rats were pur-
chased from Jung-Ang Lab Animal Inc. (Seoul, Korea).
The rats were housed individually with a 12 h light/dark
cycle at a temperature of 23 ± 1°C and a humidity of
45 ± 5% with access to water and chow diet(Samyang
Co, Incheon, Korea) for a week prior to the experiment.
For the experiment, rats were randomly divided into five
groups (n = 10 for each) and fed the designated experi-
mental diet (Table 3) for 16 weeks: high-fat diet (HF;
modified AIN-93G diet containing 41.2% energy from
fat), low-dose acetic acid (AL; HF with 6.5% (w/w) acetic
acid; equivalent to 1.6% acetic acid per rat), high-dose
acetic acid (AH; HF with 13% (w/w) acetic acid; equiva-
lent to 3.2% acetic acid per rat), low-dose PV (VL; HF
with 6.5% (w/w) PV; equivalent to 1.62% PV per rat) and
high-dose PV group (VH; HF with 13% (w/w) PV;
equivalent to 3.2% acetic acid per rat).
The AL and AH group contained the same amount of
acetic acid as the VL and VH group, respectively. The
Table 3 Composition of experimental diets
(g/kg) HF AL AH VL VH
Cornstarch 290.6 290.6 290.6 290.6 290.6
Dextrinized cornstarch 90.0 90.0 90.0 90.0 90.0
Sucrose 70.0 70.0 70.0 70.0 70.0
Casein (>85% protein) 100.0 100.0 100.0 100.0 100.0
Soybean oil 100.0 100.0 100.0 100.0 100.0
Lard 230.0 230.0 230.0 230.0 230.0
Fiber 60.0 60.0 60.0 60.0 60.0
Mineral mixa 41.0 41.0 41.0 41.0 41.0
Vitamin mixb 12.0 12.0 12.0 12.0 12.0
L-Cystine 3.5 3.5 3.5 3.5 3.5
Choline bitartrate 2.9 2.9 2.9 2.9 2.9
Tert-butylhydroquinone 0.0 0.0 0.0 0.0 0.0
Distilled water 150.0 75.0 0.0 75.0 0.0
Pomegranate vinegar (PV) 0.0 0.0 0.0 75.0 150.0
Acetic acid 0.0 75.0 150.0 0.0 0.0
Total amount 1,150.0 1,150.0 1,150.0 1,150.0 1,150.0
Total calories (kcal) 4372.7 4372.7 4372.7 4372.7 4372.7
Carbohydrates (% as kcal) 39.7 39.7 39.7 39.7 39.7
Protein (% as kcal) 19.1 19.1 19.1 19.1 19.1
Fat (% as kcal) 41.2 41.2 41.2 41.2 41.2
HF, high fat diet; AL, HF with low-dose acetic acid; AH, HF with high-dose
acetic acid; VL, HF with low-dose PV; VH, HF with high-dose PV.
aMineral mix (AIN-93G-MIX, g/kg mixture).
bVitamin mix (AIN-93G-MIX, g/kg mixture).
Ok et al. Lipids in Health and Disease 2013, 12:163 Page 7 of 8
http://www.lipidworld.com/content/12/1/163doses were determined on the basis of the previously
published studies [6,25]. Body weights and food intakes
were recorded weekly. Calorie intakes toward daily in-
takes were also converted. After the 16-week study
period, liver and white adipose tissue (WAT: epididymal
and perirenal fat pads) were removed in an overnight
fasting state and stored at −80°C before use. Blood
was also collected and quickly centrifuged at 4°C for
10 min. The serum fraction was collected and stored
at −80°C for later analysis. The experimental protocol
was approved by the Institutional Animal Care and
Use Committee (IACUC) at Ewha Womans University
(Reference # 2010-14-1).Biochemical assays
Plasma and hepatic TG were measured enzymatically
using commercially available assay kits (Asan Pharm,
Hwasung, Korea). For determination of hepatic TG con-
tent, liver tissue was homogenized and then total lipid
was extracted by Bligh’s method [26]. Plasma leptin was
measured using a radioimmunoassay kit (Invitrogen,
Carlsbad, CA, USA).Quantitative TaqMan reverse transcription polymerase
chain reaction analysis
Total RNA was extracted from liver and adipose tissue
using TRIZOL (Invitrogen Co., Carlsbad, CA, USA).
RNA concentration and quality were determined by a
BioSpec-nano (Shimadzu Corp., Kyoto, Japan). cDNA
was constructed using the High Capacity RNA-to-cDNA
kit (Applied Biosystems, Foster City, CA, USA). Quanti-
tative RT-PCR was performed using the TaqMan method
in a Step-One-Plus RT-PCR System (Applied Bio-
systems). The primer sets for target genes were PPARα
(Rn00566193_m1), SREBP-1c (Rn01446560_m1), PPARγ
(Rn00440940_m1), ACO (Rn00569216_m1), CPT-1a
(Rn00580702_m1), HSL (Rn00563444_m1), UCP2
(Rn01754856_m1) and β-actin (Rn00667869_m1). The
relative amounts of these mRNAs were normalized
to the amount of β-actin and the relative amounts of
all RNAs were calculated using the comparative CT
Method [27].Western blot analysis
Liver and adipose tissue protein was extracted with
lysis buffer (Intron Biotech, Seoul, Korea) and quanti-
fied using the Bradford method. Equal amount of proteins
were electrophoresed using 0.1% SDS-polyacrylamide gel,
transferred to polyvinylidenedifluoride membranes (Bio-
Rad, CA, USA), incubated with 5% skimmed milk in Tris-
buffered saline, and treated with rabbit anti-p-AMPK or
rabbit anti-AMPK and mouse anti-β-actin (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The immunoreac-
tive antigen was then recognized by using a horseradish
peroxidase-labeled anti-rabbit or anti-mouse IgG (Santa
Cruz Biotechnology). Immunoreactive protein bands were
visualized by ChemiDoc XRS System (Bio-Rad, CA, USA).Statistical analysis
Results were presented as mean ± standard error of
mean (SEM). Statistical analyses were performed by the
Statistical Analysis Systems package, version 9.2 (SAS
Institute, Cary, NY, USA). The differences between
treated groups were analyzed by one-way analysis of
variance (ANOVA) with post hoc Duncan’s multiple
range tests. Results were considered statistically signifi-
cant at p < 0.05.
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